QNXC yields 2000000.00% · JNJ yields 2.13%● Live data
📍 QNXC pulled ahead of the other in Year 1
Combined, QNXC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of QNXC + JNJ for your $10,000?
QENEX Communications, Inc. develops various products for the communications and energy industry. Its products include Sapphire, an ISP and enterprise class networking appliance; Ruby, a wireless Ethernet indoor/outdoor subscriber adapter; Onyx, a wireless USB indoor/outdoor subscriber adapter; GeminiVT, a virtual twin wireless technology; Plug-Inet in-building wireless distribution aid; PowerPort, a managed alternative power systems; and Regena, a productive over speed control for wind systems. The company also offers SunSpot, a multi-panel solar output booster; Micro, an anti-tamper embedded computer solution; Nano, a compact and efficient embedded computer; Picolo, a virtual computing solution; LookOut, a wireless neighborhood watch solution; and Realis, a Wireless Community Resource Management Solution. It also focuses on producing, licensing, acquiring, and distributing brand sponsored short-form films for cell phone audiences. The company is based in Corning, Arkansas.
Full QNXC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.